LINCOLNSHIRE, Ill., Sept. 1, 2016 /PRNewswire/ -- Sysmex America, Inc., a leader in hematology diagnostics, announced today that it has launched a robust line of research-use-only (RUO) single-color, monoclonal antibodies to the Americas. The reagents are available in a wide range of fluorochromes and complement Sysmex's existing flow cytometry product line including the Sysmex CyFlow® Space and CyFlow Cube cytometers as well as Celltrics® disposable filters. The new, comprehensive portfolio is available at www.sysmex.com/flowcytometry.
Sysmex's introduction of the new reagent line in the Americas signifies the company's enhanced commitment to advancements in flow cytometry and builds upon its vast knowledge of hematology. In 2014, Sysmex strengthened its global flow cytometry presence with the acquisition of Partec GmbH, a pioneer in flow cytometry, now known as Sysmex Partec GmbH.
"Our expanded product portfolio, especially the CyFlow™ single-color monoclonal antibodies, represents our global commitment to academic, pharmaceutical, industrial and clinical researchers," said Ralph Taylor, executive vice president, Sysmex America, Inc. "We look forward to offering this expanded product portfolio to the flow cytometry research community across the Americas for many years to come."
CyFlow antibodies are now available to researchers in the following areas:
- Academic and Clinical Research
- Industrial Applications: Aqua-marine studies, water quality, agronomy
- Pharmaceutical research: oncology, drug discovery and efficacy
All Sysmex flow cytometry products in the U.S.A. and Canada are for research use only. Interested parties are encouraged to visit the company's new website, www.sysmex.com/flowcytometry, or to consult with their local Sysmex flow cytometry representative.
About Sysmex America, Inc.
Sysmex America, Inc. distributes and supports a diverse portfolio of best-in-class, in vitro diagnostic hematology and clinical laboratory products in the U.S., Canada and Latin America. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex America, visit www.sysmex.com/us.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sysmex-america-inc-introduces-new-cyflow-monoclonal-antibodies-in-the-americas-300321048.html
SOURCE Sysmex America, Inc.